In 2020, the world faced an unprecedented threat when the COVID-19 epidemic swept the planet and distorted our way of life. Since the pandemic engulfed the world, the question of how to manage it and which vaccines to use has remained debatable ^[1]. But one lesson the pandemic has taught us is the need for universal, timely, equitable, and affordable access to medicine and vaccines, because no one is safe until everybody is safe. Unfortunately, what we experienced is the lack of equal, cheap, fair, safe, on-time, and universal access to medicine and vaccinations, which had a direct effect on the right to life and the right to the best possible health care for millions of people. It also caused many hospitalizations and deaths that could have been prevented. However, despite the fact that we are fortunate enough to have COVID-19 vaccinations produced in a short span of time, a strange and unwanted circumstance arose because of the unequal distribution of vaccines among different nations. It has been observed that wealthier countries acquire a significant quantity of vaccines in excess of what is required. This attitude made the pandemic even more devastating, particularly for less developed and more marginalised countries and regions. The shortages of essential medicines during the COVID-19 pandemic in various nations resurfaced the debate on universal access to medicines and patent rights. Some have blamed the unexpectedly high demand for certain medicines for the shortages. However, several thinkers in the field of global health have contended that the patent system is to blame for the legal impediments to universal access to affordable medical treatments around the globe, which is a major reason for the scarcity of medicine. This issue reached its peak after the second wave of Covid-19, when vaccines and drugs like Remdevisir, received FDA approval for Covid treatment, and it intersected with the exclusive rights of the patent owner of this medicine ^[2]. This again sparked the same global debate on patent laws and public health.